Help now

Complete index

Site map

Every page on quitting7oh.org, organized by category. Currently88 pages across 10 sections.

Looking for the search-engine sitemap? See /sitemap-index.xml.

Start Here

(8 pages)

Welcome, withdrawal planning, quitting paths, and craving moments.

  • Start here — what quitting7oh.org is, who it's for, and the page most likely to help where you are right now.

  • The 60-second elevator version: what kratom is, what 7-OH is, how it got into people's lives, and why this site exists.

  • A short map of the site, organized by where you are right now, find the one page that's most useful for what you're going through.

  • If you're in active withdrawal right now: what to do this hour, what's coming, where to get help.

  • A compact 7-OH withdrawal setup: vitamin C, basic supplements, helper medications, quitting routes, and buprenorphine access.

  • The full 7-OH withdrawal timeline, symptom relief, ER guidance, sleep, food, and what comes next.

  • Five ways people come off 7-OH and related synthetics, in the order this community would try them.

  • You're considering using again right now. Here's the one thing to do first, the people to call, and what to know about post-abstinence tolerance.

For You

(8 pages)

Treatment, work protections, mutual aid, sober living, for the person in recovery.

  • Practical resources for the person in recovery, treatment, work protections, mutual aid, and sober living. Meets you wherever you are.

  • Coming off 7-OH and kratom synthetics at home, the community-validated paths, the tools to have on hand, and when at-home isn't the right fit.

  • What a 7-OH taper actually looks like — the early dose-halving stretch, the low-dose plateau where most tapers stall, the jump-off, and what helps at each stage.

  • Detox, residential, PHP, IOP, and outpatient, what each level of care looks like, how to find a program, how to pay, and what to be skeptical of.

  • Federal job-protected leave for your own treatment, ADA protections in recovery, what HR actually sees, and how to use EAPs without your manager finding out.

  • A handful of regulated professions (CDL, pilots, ATC, law enforcement, armed security, some healthcare) treat MAT use as a licensure issue. What to check before you start.

  • Free peer support groups for the person in recovery: Kratom Anonymous (most directly applicable), NA, Heroin Anonymous, SMART, Refuge Recovery, The Phoenix, and others.

  • Sober living, defined: NARR quality levels, how to find a legitimate one, what it costs, red flags for predatory homes, and how Oxford House differs.

For Loved Ones

(11 pages)

For family, partners, and friends of someone struggling: what to expect, how to help, how to stay safe.

  • If you love someone using 7-OH, MGM-15, or kratom-derived synthetics, this is where to start — a calm reference for the family side of recovery.

  • Dependence on 7-OH and kratom-derived synthetics as it looks from outside, what withdrawal does to the brain and body, and the long PAWS tail families don't get warned about.

  • When to bring it up, how to say it, and a primer on CRAFT — the evidence-based framework that outperforms Al-Anon and confrontational interventions for getting a loved one into treatment.

  • How to set limits that protect your life without trying to control your loved one's — what a boundary actually is, and how to follow through without becoming cruel.

  • If you or your children are in danger: recognizing escalation, safety planning, mandatory reporters, the crisis hotlines, and how to use naloxone (Narcan).

  • When the person you love needs to leave the home and won't go: the legal landscape, protective orders, and where to find free legal help.

  • What at-home recovery from 7-OH and kratom-derived synthetics looks like from outside, the tools your loved one is using, and when to push for higher-intensity care.

  • Detox, residential, PHP, IOP, and outpatient, from the family's perspective — insurance, parity law, free paths, and how to spot predatory treatment marketing.

  • Federal job-protected leave to care for a family member in addiction treatment. Eligibility, what counts, who's covered, state expansions, and EAPs.

  • The unglamorous basics that keep you standing — therapy, support groups, sleep, the hypervigilance trap, and why it's okay to be happy while your loved one isn't.

  • Peer support groups for people with a loved one in addiction: Nar-Anon, SMART Recovery Family & Friends, Learn to Cope, the kratom-specific options, and others.

COWS, induction, tapers, risks, custom dosing.

  • Timing your first Suboxone dose by your withdrawal score, not the clock. SOWS is the self-scoring tool for inducting at home; COWS is the clinician version.

  • Suboxone for coming off 7-OH and kratom synthetics. Induction, low-and-slow dosing, short-taper schedules, and the receptor pharmacology behind the approach.

  • The Bernese Method — low-dose Suboxone induction with overlapping full-agonist use. Original protocol, modern variants, and where it fits for kratom synthetics.

  • A 5-to-10-day Suboxone taper used by people coming off short-acting 7-OH.

  • Liquid titration for doses below 0.5 mg, when pill cuts can't get you low enough to finish a taper.

  • Sublocade and Brixadi — long-acting buprenorphine injections for maintenance, the long discontinuation tail, and the single-shot exit strategy.

  • Why bupe sometimes doesn't cover you: serotonergic and adrenergic symptoms, the dose-ceiling question, long-acting compounds.

  • Long-term Suboxone effects, dependence, hormone changes, and tapering off — including the long-acting injectables some people use to exit.

Helper meds, supplements, quit-kit stacks, NAD+ IV, peptides, tapering with leaf, cannabis in recovery.

  • Helper medications for 7-OH and kratom-synthetic withdrawal — clonidine, gabapentin, baclofen, trazodone, ondansetron — with symptom-by-symptom dosing.

  • A community-tested supplement stack for 7-OH and kratom-synthetic withdrawal and PAWS — what to start with, what to skip.

  • Honest review of two commercial supplement stacks marketed for kratom and opioid withdrawal, what's in them, what they cost, and what to know before buying.

  • High-dose vitamin C may ease opioid withdrawal.

  • Using plain kratom leaf as a bridge off concentrated 7-OH and other kratom synthetics, when it works, when it doesn't, and how to taper the leaf afterward.

  • Concentrated mitragynine extracts as a bridge from 7-OH to abstinence — doses, timelines, the contamination concern, and how it compares to the other paths off.

  • SR-17018 went into Schedule I on August 27, 2026. What the order covers, what it means if you are mid-taper, and the community protocol this site documented while it was unscheduled.

  • NAD+ infusions for 7-OH and kratom recovery — what's offered, what it costs, what the published evidence supports, and where it falls short.

  • Peptides used as adjuncts in 7-OH and kratom-synthetic recovery — BPC-157, Selank, Semax, DSIP, TB-500 — the evidence and the unregulated-supply safety concerns.

  • Cannabis and THC during acute withdrawal and PAWS from 7-OH and kratom — benefits, harms, the cannabinoid landscape, and how to think about the call.

Post-Acute

(13 pages)

PAWS, sleep recovery, dopamine recovery, endocrine recovery, naltrexone.

  • Post-acute withdrawal syndrome, what it is, when it shows up, what symptoms look like, the neurobiology behind it, and what helps, labeled by evidence level.

  • The early-recovery stretch of unexpected well-being some people hit after acute withdrawal — what it is, how to use the window, and what comes next.

  • Flat motivation and anhedonia in the months after 7-OH and kratom synthetics: what helps, the realistic timeline, and the pseudoscience to skip.

  • The depression and anhedonia that show up in the weeks and months after coming off 7-OH and kratom synthetics — the distinction, what helps, when to escalate.

  • The specific terror that hits in withdrawal and PAWS — feeling like something catastrophic is about to happen. What it is, what to do right now, when it's more than withdrawal.

  • Sleep recovery after coming off 7-OH and kratom synthetics — what's normal, what helps, and how long it actually takes.

  • 7-OH and kratom synthetics suppress the hormone systems chronically. What you may experience months in, the testing workup, the recovery picture, and what's specific to men and to women.

  • What happens if you use again after a stretch off — why withdrawal can come back fast, what the OUD literature shows, what this community reports about 7-OH.

  • What recovery from 7-OH dependence actually looks like — how hard it is, how relapse fits, and why the long-arc picture borrows from OUD literature.

  • Naltrexone in three dose tiers — normal-dose for abstinence after detox, low-dose (LDN) for PAWS, and ultra-low-dose (ULDN) as an investigational adjunct.

  • Full-dose naltrexone — oral 50 mg daily and Vivitrol 380 mg monthly — for sustained abstinence after detox. With the precipitated-withdrawal safety warning.

  • Low-dose naltrexone (LDN) at a small fraction of the standard dose — off-label for chronic pain, autoimmune conditions, and as a post-acute adjunct. Evidence and caveats.

  • Ultra-low-dose naltrexone (ULDN) at microgram doses taken alongside opioids — the investigational concept, the thin clinical evidence, why it isn't standard care.

Compounds

(8 pages)

7-OH, pseudo, MGM-15, MIT-A, mitragynine, cat’s claw, and the federal scheduling action.

  • Pseudo, MGM-15, and MGM-16 are Schedule I as of August 26, 2026. The 7-OH threshold order is still pending. Dates, scope, the closed comment period, and what to do if you're still using.

  • Kratom basics, what mitragynine does in the body, how it relates to 7-OH, and why concentrated 7-OH products are not the same thing as leaf.

  • Concentrated 7-hydroxymitragynine, how it differs from kratom leaf, why dependence builds fast, and what makes it taperable.

  • MGM-15 (dihydro-7-hydroxymitragynine), the long-acting reduced 7-OH. The same compound sold under the labels MIT-A and (mislabeled) DHM. Chemistry, the COA-testing problem, regulatory landscape, taper plan, Suboxone induction notes.

  • The fluorinated analog of MGM-15, a 2014 medicinal-chemistry compound named in scheduling proceedings but not documented in any US consumer product to date.

  • Products marketed as MIT-A or DHM contain MGM-15. The full picture lives on the MGM-15 page; this page is a pointer.

  • Mitragynine pseudoindoxyl (MP), receptor affinity, why bupe induction is harder, what to watch for.

  • Products marketed as 'Cat's Claw' or 'Rhynchophylline' at smoke shops and gas stations are being built around corynoxine B, an opioid-active alkaloid that dodges the 7-OH scheduling. What's really in them.

Pharmacology

(3 pages)

Deeper science: receptor binding, structure-activity, minor alkaloids.

  • Laboratory evidence on selected kratom alkaloids at opioid, serotonin, and adrenergic receptors, with the limits of each assay.

  • A comparison of structure, receptor affinity, signaling, and evidence limits for morphine and mitragynine-derived compounds.

  • A visual guide to mitragynine, kratom alkaloids, 7-hydroxymitragynine, and related metabolites and derivatives.

Resources

(9 pages)

Telehealth, recovery coaching, meetings, calculators, finding help.

  • Numbers for the moments that can't wait: suicide, medical emergency, treatment referrals, domestic violence, child abuse, poison control.

  • Side-by-side comparison of telehealth providers that prescribe Suboxone for kratom and 7-OH dependence — pricing, scope, and what they'll work with.

  • Live meeting schedules for the two kratom-specific fellowships — Kratom Anonymous (12-step) and Quitting Kratom Support - There Is A Way Out / TIAWO (non-12-step). Day, time, format, join links.

  • What peer recovery coaching is, what it costs, and how to weigh a paid service like You Are Accountable against the free peer support this community already runs.

  • Day-by-day taper calculators for 7-OH and kratom synthetics, buprenorphine, and kratom leaf, plus the SR-17 taper kept for readers mid-taper. Pick the one that matches your path.

  • Day-by-day taper schedule for 7-OH, MGM-15 (sold as MIT-A or DHM), and pseudoindoxyl — enter a dose and speed, get the math, save as PDF, or copy an AI prompt.

  • Day-by-day buprenorphine taper schedule with the published 5/7/10/14/21-day rapid-taper columns built in, plus custom-duration math for non-standard start doses.

  • Day-by-day kratom leaf taper schedule in grams, with a configurable jump-off so the taper ends at a tolerable low dose rather than crashing to zero.

  • Build a simple 7, 10, or 14-day 7-OH to SR-17 cross-taper, or switch to the configurable advanced calculator. Kept for readers already mid-taper after SR-17018 went into Schedule I.

About the site, its community, technical architecture, changelog, and ways to contribute.

  • What quitting7oh.org is, who it serves, how the team uses AI, and where to go next.

  • The quitting7oh Discord and r/quitting7oh subreddit, how the community started, and the people currently running it.

  • Suggest corrections, propose changes, or reach the maintainers — via GitHub PR, Discord, subreddit modmail, or email.

  • On responsible kratom and 7-OH use, the site's recovery focus, and why the site doesn't take a position on bans.

  • Recent changes to quitting7oh.org: new pages, rewrites, design tweaks, and editorial sweeps. Newest entries first.

  • Source notes for the community knowledge behind quitting7oh.org.

  • The software, build pipeline, deployment targets, and design system behind quitting7oh.org.

Standalone tools

(3 pages)

Live, shareable landing pages that don't belong to a category — designed to be linked directly.